Five disciplines. One accountable team.

RegulatoryX puts senior, named expertise behind the clinical, regulatory, writing, data and digital decisions that determine whether a programme is fundable, approvable and credible.

Start a conversation ↗Discuss talent needs →

WORKING METHOD●

01Question

02Evidence

03Action

FocusDecision-ready direction

WHERE WE HELP

Connected expertise across the development pathway

REGULATORY

Regulatory strategy & leadership

Health-authority positions, submission strategy and fractional regulatory leadership across FDA, EMA and MHRA pathways.

Explore regulatory →

CLINICAL

Clinical development decisions

Pathway, trial design and precision-medicine decisions resolved through a senior-led, time-boxed process.

Explore clinical →

WRITING

Regulatory & medical writing

Submission-ready documents shaped around the objective, audience, evidence and health-authority expectations.

Explore writing →

DATA

Data & biostatistics

Data strategy, standards, analytics and biostatistics that turn programme evidence into decision-ready insight.

Explore data →

DIGITAL R&D

Digital & responsible AI

Systems, workflow design and evidence-led AI evaluation for regulated R&D — expert-led, never autonomous.

Explore digital →

WHO WE HELP

Biotech, technology & investors

See how these services apply to your organisation, stage and decision.

See who we help →

HOW ENGAGEMENTS START

Buy a defined result — not an open-ended consultancy

Every engagement starts with a named decision, a fixed scope and a senior owner. Fractional leadership and expert pods extend delivery capacity once the first engagement has proven its value — nothing is staffed by default.

START WITH THE CONSTRAINT

What is slowing your programme — or which capability is your team missing?

Tell us the decision, deliverable or role you are working through. We will help identify the most useful next step.

Start a conversation ↗Explore our services →